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Internalization and vacuolar targeting of the
brassinosteroid hormone receptor BRI1 are
regulated by ubiquitination
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Brassinosteroids are plant steroid hormones that control many aspects of plant growth and
development, and are perceived at the cell surface by the plasma membrane-localized
receptor kinase BRI1. Here we show that BRI1 is post-translationally modiﬁed by K63
polyubiquitin chains in vivo. Using both artiﬁcial ubiquitination of BRI1 and generation of an
ubiquitination-defective BRI1 mutant form, we demonstrate that ubiquitination promotes BRI1
internalization from the cell surface and is essential for its recognition at the trans-Golgi
network/early endosomes (TGN/EE) for vacuolar targeting. Finally, we demonstrate that the
control of BRI1 protein dynamics by ubiquitination is an important control mechanism for
brassinosteroid responses in plants. Altogether, our results identify ubiquitination and
K63-linked polyubiquitin chain formation as a dual targeting signal for BRI1 internalization and
sorting along the endocytic pathway, and highlight its role in hormonally controlled plant
development.
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B
rassinosteroids (BRs) are polyhydroxylated steroid hor-
mones that regulate plant growth and development1.
Studies of mutants with defects in BR biosynthesis or
signalling demonstrated that BRs play essential roles in nearly all
phases of plant development, as these mutants show multiple
developmental defects, such as reduced seed germination,
extreme dwarﬁsm, photomorphogenesis in the dark, altered
distribution of stomata, delayed ﬂowering and male sterility1,2.
BRs are perceived at the cell surface by the membrane-bound
receptor complex composed of the BRASSINOSTEROID
INSENSITIVE1 (BRI1) receptor kinase and BRI1-
ASSOCIATED RECEPTOR KINASE1 (BAK1)3–5. Ligand-
dependent auto- and trans-phosphorylation of BRI1 and BAK1
participate in receptor complex activation and modulate a cellular
cascade of kinases and phosphatases6,7, which ultimately
culminates in the dephosphorylation and activation of two
transcription factors, BRASSINAZOLE-RESISTANT1 (BZR1)
and BRI1-EMS SUPPRESSOR1 (BES1)8,9. BES1 and BZR1 bind
to target promoters in the presence of different interacting
partners to regulate BR genomic responses10–12.
Adjustments in subcellular distribution of cell surface receptors
are critical to modulate their signalling activity. Over the past
decade, BRI1 has served as a model for a better understanding of
the interplay between receptor trafﬁcking, signal transduction and
deactivation. BRI1 constitutively cycles between the plasma
membrane and the trans-Golgi network/early endosome (TGN/
EE), and it is targeted to the vacuole for degradation via the late
endosomes/multivesicular bodies (MVB), independently of its
ligand13,14. Internalization of BRI1 involves clathrin-mediated
endocytosis, the adaptor complex AP-2 and the guanine exchange
factor for ADP-ribosylation factor GTPase (ARF-GEFs) GNOM
and GNL1 (refs 15,16). The drug-mediated trapping of BRI1 in
endosomes was shown to enhance BR responses, leading to a
model whereby BRI1 signals preferentially from endosomal
compartments13. However, blocking BRI1 internalization by
genetic or pharmacological interferences with AP2 was shown
to activate BR signalling, indicating that BRI1 signals from the
plasma membrane15,16.
The post-translational modiﬁcation of proteins involving
ubiquitin (Ub) is well known in yeast and mammals to target
proteins to proteasome-mediated degradation, and this involves
K48-linked polyubiquitin chains17. Ubiquitination also serves
numerous proteasome-independent roles, including the
endocytosis of membrane proteins18. Notably, K63-linked
polyubiquitin chains are essential for endosomal sorting and
lysosome/vacuolar delivery of cargos via recognition by the ESCRT
complex19. Ubiquitination also controls early steps of plasma
membrane protein internalization. In yeast, Ub-mediated
internalization is the major mechanism allowing retrieval of
plasma membrane proteins20, while several other redundant Ub-
independent pathways exist in mammals21. In plants, Ub-mediated
endocytosis emerged only very recently with the study of ion and
hormone transporters22–26. To date, the role of ubiquitination in
the dynamics of plant transporters appears restricted to their
targeting to the vacuole23,24. Whether Ub-mediated endocytosis
has also been co-opted for driving the trafﬁcking of other types of
plant plasma membrane proteins, such as receptors, and for
triggering early steps of internalization from the cell surface is
unclear. Although several plant E3 ubiquitin ligases have been
shown to interact with receptors27–30, their direct role in receptor
ubiquitination has not been shown. Only the ubiquitination of the
cell-surface ﬂagellin receptor FLS2 by the PUB12 and PUB13 E3
ligases has been experimentally demonstrated; however, its link
with FLS2 endocytosis is still undocumented31.
Here we demonstrate that BRI1 is post-translationally modiﬁed
by K63 polyubiquitin chains in vivo. Artiﬁcial ubiquitination of
BRI1 negatively regulates its activity by enhanced vacuolar
targeting from TGN/EE. Mass spectrometry analyses identify
residue K866 of BRI1 as a target of ubiquitination in vivo. Loss of
BRI1 ubiquitination at residue K866 is associated with subtle BR
hypersensitivity, conﬁrming the negative role of BRI1 ubiquitina-
tion on BR signalling, and pointing to the existence of other
ubiquitination sites in BRI1. Model-based prediction of cell
surface-exposed lysine residues in BRI1 allowed the generation of
a functional but ubiquitination-defective BRI1. Global loss of
BRI1 ubiquitination is associated with major defects in endoso-
mal sorting and vacuolar delivery. In addition, using total internal
reﬂection ﬂuorescence microscopy (TIRF), we also shed light on
the role of BRI1 ubiquitination in the BRI1 internalization from
the cell surface. Altogether, our results identify K63-linked
polyubiquitin chain formation as a dual targeting signal for
BRI1 internalization and sorting along the endocytic pathway,
and uncover its role in hormonally controlled plant development.
Results
BRI1 receptor is ubiquitinated in vivo. Earlier work
demonstrated that BRI1 undergoes endocytosis and trafﬁcking to
the vacuole, independently of its activation state13. However,
little is known about the mechanisms driving BRI1 protein
dynamics in the cell. Ubiquitination of cell-surface receptors in
yeast and mammals has been shown to control internalization
and/or vacuolar/lysosomal targeting18. To investigate BRI1
ubiquitination and its possible role in BR signalling, we used
previously characterized transgenic lines expressing the
functional BRI1–mCitrine fusion protein in complemented bri1
null mutants32, or in its isogenic wild-type background33, under
the control of BRI1 promoter to reach endogenous expression
level (Supplementary Fig. 1a). We ﬁrst used anti-GFP antibodies
to immunoprecipitate BRI1 from BRI1–mCitrine-expressing
plants or wild-type plants as control. Immunoprecipitates
from BRI1–mCitrine-expressing plants were enriched in BRI1–
mCitrine, as attested by the strong signal observed at the expected
size of BRI1–mCitrine fusion protein (B170 kDa; Fig. 1, top
left panel). To evaluate whether a fraction of BRI1 is post-
translationally modiﬁed by ubiquitination, immunoprecipitates
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Figure 1 | BRI1 carries K63 polyubiquitin chains in vivo. In vivo
ubiquitination analyses of BRI1. Immunoprecipitation was performed using
anti-GFP antibodies on solubilized protein extracts from wild-type and
mono-insertional homozygous BRI1–mCitrine plants and subjected to
immunoblotting with anti-GFP (top left), anti-Ub P4D1 (top right), anti-K63
polyUb Apu3 (bottom left) and anti-K48 polyUb Apu2 antibodies (bottom
right). IB, immunoblotting; IP, immunoprecipitation. The asterisk indicates
nonspeciﬁc signals used as loading control.
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were probed with the general P4D1 anti-ubiquitin antibodies that
recognize monoubiquitin and several forms of polyubiquitin
chains. A high molecular weight smear, typical of ubiquitinated
proteins, was speciﬁcally observed fromB170 kDa and higher in
immunoprecipitates from BRI1–mCitrine plants (Fig. 1, top right
panel). A comparable high molecular weight smear was observed
when using the widely used Apu3 K63 polyubiquitin chain-
speciﬁc antibody34, indicating that BRI1 is decorated by K63
polyubiquitin chains in vivo (Fig. 1, bottom left panel). In
contrast, BRI1 immunoprecipitates showed no signal when
probed with a K48 polyubiquitin chain-speciﬁc Apu2
antibody34, highlighting the fact that BRI1 does not carry
K48-linked polyubiquitin chains (Fig. 1, bottom right panel).
We next addressed whether ubiquitination of BRI1 was
regulated by steroid hormone perception. Challenging
BRI1–mCitrine-expressing plants for 1 h with 1mM brassinolide
(BL), the most active BR form, had no detectable effect on the
ubiquitination proﬁle of BRI1–mCitrine (Fig. 2a; Supplementary
Fig. 1b). This concentration and duration of treatment is
routinely used to monitor BR responses, such as the depho-
sphorylation of BES1 and BZR1 transcription factors11,35–37,
suggesting that BRI1 ubiquitination does not correlate with ligand
binding. It is possible however that under our growth conditions
such young growing BRI1–mCitrine plants have close-to-
maximal levels of activated receptors, thus preventing the
detection of ligand-dependent changes in BRI1 ubiquitination.
Two lines of evidence argue against this hypothesis. First, BRI1–
mCitrine plants are fully responsive to exogenously applied BL, as
observed by the marked change in BES1 phosphorylation status
(Supplementary Fig. 1c), indicating that BR responses are not
saturated. Second, growing plants on the BR biosynthetic
inhibitor brassinazole (BRZ) to deplete the endogenous
pool of BRs before a 1-h-BL treatment had no effect on BRI1
ubiquitination (Supplementary Fig. 1d,e). Interestingly, a 15-min-
BL treatment revealed a modest increase in BRI1 ubiquitination
(Supplementary Fig. 1f,g). Such a short BL treatment was
sufﬁcient to trigger total dephosphorylation of BES1
(Supplementary Fig. 1h), highlighting the fact that BRI1 kinase
is activated within minutes after ligand binding. Altogether, these
observations indicate that BRI1 ubiquitination appears to be
largely independent of ligand binding with its regulation by BRs
restricted to early BR receptor complex activation.
Mechanism of BRI1 ubiquitination. We next investigated the
molecular mechanisms driving BRI1 ubiquitination. In particular,
we focused on the possible role played by receptor activation,
although BRI1 ubiquitination appears to be mostly independent
of ligand binding. Lysine residue K911 of BRI1 is an invariant
residue in subdomain II of kinases and is critical for BRI1 kinase
activity and BR signalling. Consequently, bri1 mutant expressing
the kinase-dead K911R mutation is not complemented and
show extreme dwarﬁsm38. Transgenic plants expressing the
non-functional BRI1K911R mutant form under the control of the
BRI1 promoter were assayed for BRI1 ubiquitination. Care was
taken to normalize the immunoprecipitation carried out from
BRI1–mCitrine- and BRI1K911R–mCitrine-expressing plants to
compensate for difference in transgene expression level. In
contrast to what is observed for the wild-type form of BRI1,
BRI1K911R-expressing plants showed reduced ubiquitination
(Fig. 2b, Supplementary Fig. 1i). This suggests that BRI1 kinase
activity is required for BRI1 ubiquitination. The possibility
that residue K911 itself is a major ubiquitination site in the
BRI1 protein is very unlikely, since it is not surface-exposed
(Supplementary Fig. 5a). Mutation in K911 of BRI1 was shown to
drastically affect BRI1–BAK1 receptor complex formation39.
We therefore addressed whether the co-receptor BAK1
was also required for BRI1 ubiquitination. To this purpose, we
expressed BRI1–mCitrine in a bak1 null mutant background.
bak1-3/BRI1–mCitrine showed a reduction in BRI1
ubiquitination compared with BRI1–mCitrine plants, although
not statistically signiﬁcant (Fig. 2b, Supplementary Fig. 1i).
The defect in BRI1 ubiquitination observed in bak1-3 is less
severe than what is observed for kinase-dead BRI1, likely because
of genetic redundancy with other BAK1 homologues40.
The defect of BRI1 ubiquitination observed in genetic
backgrounds impaired in receptor complex activation is
however not explained by a different subcellular distribution of
BRI1 in the cell. BRI1 is indeed found both at the plasma
membrane and in endosomal compartments in BRI1–mCitrine
and bak1-3/BRI1–mCitrine, as well as in BRI1K911R–mCitrine
plants, although the expression level of kinase-dead BRI1 is very
low (Supplementary Fig. 1j). Altogether, these results indicate
that, although BRI1 ubiquitination is largely independent of
steroid binding, it requires BRI1 kinase activity and, to a lesser
extent, its co-receptor BAK1—two hallmarks of ligand perception
by BRI1 (ref. 1).
BRI1 artiﬁcial ubiquitination triggers vacuolar targeting.
Extensive work in yeast and mammals demonstrated the
importance of mono- and K63 polyubiquitination for plasma
membrane protein internalization, and sorting in MVB20,41.
However, K63 polyubiquitination has also been involved in the
regulation of kinases. TAK1 (transforming growth factor-b
activating kinase 1) mediates NF-kB activation in response to
the activation of the TGF-b receptor. Upon stimulation with
TGF-b, TAK1 undergoes TRAF6-dependent K63-linked
ubiquitination on residue K34. Modiﬁcation of TAK1 by
ubiquitination is critical for TAK1 autophosphorylation and
subsequent activation42. To get a ﬁrst glimpse into the biological
role of BRI1 post-translational modiﬁcation by K63
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Figure 2 | BRI1 is ubiquitinated largely independently of ligand binding.
(a) Ligand dependency of BRI1 ubiquitination. Ubiquitination assays were
performed on wild-type and BRI1–mCitrine plants treated with mock ( BL)
or 1mM BL (þBL) for 1 h. The asterisk indicates nonspeciﬁc signals used as
loading control. (b) BRI1 ubiquitination in mutants affected in receptor
complex activation. Ubiquitination assays were performed on mono-
insertional homozygous BRI1–mCitrine, kinase-dead BRI1K911R–mCitrine and
bak1-3/BRI1–mCitrine lines. The asterisk indicates nonspeciﬁc signals used
as loading control.
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polyubiquitination, we took a gain-of-function approach where
BRI1–mCitrine was translationally fused to a single Ub moiety.
Although BRI1 is artiﬁcially linked to a single Ub, seven lysine
residues are found in Ub including lysine K63 that may engage in
K63 polyUb chain formation. We used the complementation of
the dwarﬁsm of the bri1 null T-DNA knockout mutant32, as
readout for BRI1 activity (Supplementary Fig. 2a). As controls, we
also generated bri1/BRI1–mCitrine, as well as bri1/BRI1–
mCitrine–UbI44A carrying a point mutation in a hydrophobic
patch necessary for recognition by ubiquitin-binding domain
proteins43. Care was taken at that stage to use transgenic lines
expressing similar amounts of RNA for the respective transgenes
(Supplementary Fig. 2b). Both bri1/BRI1–mCitrine and bri1/
BRI1–mCitrine–UbI44A, expressing a non-functional ubiquitin,
fully complemented the severe dwarﬁsm of bri1 null mutant
(Fig. 3a). In contrast, BRI1–mCitrine–Ub did not complement
the bri1 phenotype, indicating that artiﬁcial ubiquitination
of BRI1 downregulates its activity. Artiﬁcial ubiquitination of
BRI1–mCitrine protein led to a strong decrease in total BRI1
protein levels compared with wild-type BRI1–mCitrine and
BRI1–mCitrine–UbI44A (Fig. 3b, Supplementary Fig. 2c).
Confocal microscopy observations, using similar detection
settings to compare the ﬂuorescence levels of the three
transgenic lines and to quantify total ﬂuorescence intensity,
clearly indicate that BRI1–mCitrine–Ub fails to accumulate in the
cell (Fig. 3c,d). Higher laser intensity and gain, however, allowed
the detection of close-to-background levels of BRI1–mCitrine–Ub
as punctate pattern, with little or no accumulation at the plasma
membrane (Fig. 3c, inset).
To investigate deeper the mechanisms driving the loss of
BRI1–mCitrine–Ub protein, we took advantage of drugs
interfering with vesicular trafﬁcking. The fungal toxin Brefeldin
A (BFA) is a widely used inhibitor of endosomal trafﬁcking,
creating large aggregates of trans-Golgi network/early endosomal
compartments in the Arabidopsis root. Although BRI1–mCitrine–
Ub failed to accumulate under normal conditions, BRI1–
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Figure 3 | Artiﬁcial ubiquitination of BRI1 triggers vacuolar targeting from TGN/EE. (a) Phenotypic analysis of transgenic plants expressing BRI1–
mCitrine, BRI1–mCitrine–Ub and BRI1–mCitrine–UbI44A in the bri1 null background. All transgenic lines are mono-insertional and homozygous for the
transgene. A representative transgenic line is shown for each genotype. (b) Western blot analyses monitoring BRI1 protein accumulation in bri1/BRI1–
mCitrine, bri1/BRI1–mCitrine–Ub and bri1/BRI1–mCitrine–UbI44A plants using anti-GFP antibodies. The asterisk indicates nonspeciﬁc signals used as loading
control. (c) Confocal microscopy analyses of bri1/BRI1–mCitrine, bri1/BRI1–mCitrine–Ub and bri1/BRI1–mCitrine–UbI44A roots. Similar confocal detection
settings were used to compare the different lines. Inset, higher laser power and gain to visualize BRI1–mCitrine–Ub. Scale bars¼ 50mm. (d) Quantiﬁcation
of the total ﬂuorescence intensity of bri1/BRI1–mCitrine, bri1/BRI1–mCitrine–Ub and bri1/BRI1–mCitrine–UbI44A roots. Experiments were conducted in
triplicates. Error bars represent s.d. (n¼ 15). The asterisks indicate a statistically signiﬁcant difference between bri1/BRI1–mCit–Ub and the bri1/BRI1–mCit
control by Kruskal–Wallis one-way analysis of variance and Dunnett multiple testing (Po0.0001). (e) Drug sensitivity of bri1/BRI1–mCitrine and bri1/BRI1–
mCitrine–Ub plants. Plants were exposed to BFA (50mM) and ConA (2 mM) for 1 h. Similar confocal detection settings were used to compare the different
lines. Inset, higher magniﬁcation to visualize the accumulation of BRI1–mCitrine and BRI1–mCitrine–Ub ﬂuorescent proteins in BFA bodies and vacuoles
upon BFA and ConA treatment, respectively. Scale bars¼ 50mm.
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mCitrine–Ub levels rapidly built up in BFA bodies after BFA
treatment to reach the levels observed for BRI1–mCitrine (Fig. 3e,
Supplementary Fig. 3a). This suggests that BRI1–mCitrine–Ub is
translated, exits the endoplasmic reticulum and passes through
the TGN/EE on its way to degradation. We next assessed the
inﬂuence of the vacuolar ATPase inhibitor Concanamycin A
(ConA), which prevents the degradation of proteins targeted to
the vacuole44. ConA treatment led to the dramatic accumulation
of BRI1–mCitrine–Ub in the vacuole (Fig. 3e, Supplementary
Fig. 3b), compared with BRI1–mCitrine, thus revealing enhanced
vacuolar delivery triggered by ubiquitin. This indicates that
artiﬁcial ubiquitination of BRI1–mCitrine is sufﬁcient for
vacuolar targeting, consistent with what has been recently
observed for other plant cargos24,45,46. We next investigated
whether BRI1–mCitrine–Ub was trafﬁcking via the plasma
membrane on its way to the vacuole by inhibiting clathrin-
mediated endocytosis, the major endocytic road in plants47.
Treatment with the inhibitor of clathrin-mediated endocytosis,
TyrA23, was ineffective at stabilizing BRI1–mCitrine–Ub at the
cell surface, but rather led to a cytosolic-like pattern of
ﬂuorescence (Supplementary Fig. 3c). In contrast, TyrA23
prevented the formation of BFA bodies in BRI1–mCitrine
plants (Supplementary Fig. 3d), attesting that TyrA23 treatment
was active. Taken together, these results indicate that artiﬁcial
ubiquitination is recognized before reaching the plasma
membrane, likely at the TGN/EE, and serves as a targeting
signal for degradation in the vacuole.
To discriminate further the form of Ub associated with
vacuolar targeting, we generated bri1/BRI1–mCitrine–Ub7KR
plants where all seven lysines from Ub were mutated to arginines
to prevent K63 polyubiquitin chain formation. Confocal micro-
scopy observations of bri1/BRI1–mCitrine and bri1/BRI1–mCi-
trine–Ub7KR using the same detection settings showed that
artiﬁcial monoubiquitination of BRI1 also impairs BRI1 protein
accumulation (Supplementary Fig. 3e,f). Monoubiquitination of
BRI1 therefore appears sufﬁcient to trigger its vacuolar delivery,
similarly to what has been reported for the plant ATPase phorbol
myristate acetate or the yeast polyphosphate endophosphatase
Phm5 (refs 45,48).
BRI1 is ubiquitinated at residue K866 in vivo. To identify
ubiquitination sites in BRI1, we performed immunoprecipitation
of BRI1 in the presence of deubiquitinase inhibitors followed by
mass spectrometry analyses. Immunopuriﬁed BRI1–mCitrine was
digested by trypsin and subjected to liquid chromatography
tandem mass spectrometry analyses (LC-MS/MS). Multi-
dimensional protein identiﬁcation technology analyses on BRI1–
mCitrine immunoprecipitates detected nine BRI1 peptides,
including the EALSINLAAFEKGGPLR peptide modiﬁed by the
tryptic ubiquitin remnant G–G isopeptide on the lysine residue
K866. This residue lies on the cytosolic face of the BRI1 protein,
in the juxtamembrane domain (Fig. 4a). To examine the biolo-
gical role of K866 ubiquitination, we generated transgenic plants
expressing BRI1 where residue K866 is substituted by the posi-
tively charged but nonubiquitinatable R residue (BRI1K866R),
under the control of its own promoter in bri1 background. bri1/
BRI1K866R–mCitrine transgenic plants expressing similar BRI1–
mCitrine levels than bri1/BRI1–mCitrine showed no macroscopic
phenotypes at the adult stage (Fig. 4b,c). To better characterize
BRI1K866R-expressing plants, we monitored two well-established
readouts of BR signalling such as the phosphorylation state of
BES1 and hypocotyl length. Compared with plants expressing
wild-type BRI1, BRI1K866R-expressing plants reproducibly
showed more dephosphorylated BES1 (Fig. 4c; Supplementary
Fig. 4a) and longer hypocotyls when grown under both normal
conditions and BRZ (Fig. 4d). These observations suggest that
expression of BRI1K866R leads to a mild activation of BR signal-
ling. No striking difference on the localization and the levels of
the BRI1K866R–mCitrine protein could be observed (Fig. 4e).
Altogether, ubiquitination of residue K866 appears to
play a negative role on BRI1 activity. The fact that bri1/
BRI1K866R–mCitrine transgenic plants only show a slight activa-
tion of BR signalling compared with what has been reported for
BRI1-overexpressing plants33, and still harbours massive
ubiquitination (Supplementary Fig. 4b,c) suggests that many
more ubiquitination sites exist in BRI1.
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peptide carrying the GG di-glycine signature on K866 is shown. (b)
Phenotypic analysis of 4-week-old mono-insertional homozygous bri1/BRI1-
mCitrine and bri1/BRI1K866R-mCitrine plants. A representative transgenic
line is shown for both genotypes (c) Western blot analyses on bri1/BRI1-
mCitrine and bri1/BRI1K866R-mCitrine plants. Protein levels were detected
with anti-GFP and anti-BES1 antibodies, respectively. (d) Average hypocotyl
lengths of 3-day-old etiolated bri1/BRI1-mCitrine and bri1/BRI1K866R-
mCitrine seedlings. Experiments were done in triplicates. Error bars indicate
standard deviation (n¼ 15). The asterisks indicate a statistically signiﬁcant
difference between bri1/BRI1-mCit and the bri1/BRI1K866R-mCit control
(Mann-Whitney, Po0.0001). (e) Confocal microscopy analyses of bri1/
BRI1-mCitrine and bri1/BRI1K866R-mCitrine roots. Similar confocal detection
settings were used to compare the two representative transgenic lines.
Inset, higher magniﬁcation. Scale bars¼ 50mm.
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Loss of BRI1 ubiquitination impairs endocytosis and sorting.
The intracellular domain of BRI1 contains 29 lysine residues.
Sequence alignment of BRI1 with (i) the BRI1-like homologues
from Arabidopsis, (ii) BRI1 from other plant species, (iii) Ara-
bidopsis receptor kinases belonging to different subfamilies such
as FLS2 and CLV1 and (iv) human IRAK4 indicates that four
lysines from BRI1 kinase are highly conserved in all kinases
analysed. These include the ATP-binding pocket-located K899,
K911 and K912, and residue K1011 in the catalytic loop, which
are mostly buried in the recently resolved BRI1 kinase structure49
(Supplementary Fig. 5a), and are likely critical for kinase activity
since highly conserved. To pinpoint the role of BRI1
ubiquitination, we sought to generate an ubiquitination-
defective BRI1 that retains its kinase activity. We therefore
mutated 25 lysines to arginines in BRI1 intracellular domain, and
kept only the four strictly conserved lysine residues K899, K911,
K912 and K1011. Expression of the resulting BRI125KR mutants
under the control of BRI1 promoter complemented the dwarf
phenotype of bri1 null mutant (Fig. 5a). This result indicates that
BRI125KR–mCitrine was still functional and that none of these 25
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Figure 5 | BRI1 ubiquitination controls brassinosteroid signalling and BRI1 localization. (a) Phenotypic analysis of 4-week-old bri1/BRI1–mCitrine and
bri1/BRI125KR–mCitrine mono-insertional homozygous plants. A representative transgenic line is shown for both genotypes. (b) Average petiole lengths of
the fourth true leaf from 4-week-old bri1/BRI1–mCitrine and bri1/BRI125KR–mCitrine plants. Experiments were carried out in triplicates. Error bars represent
s.d. (n¼ 20). The asterisk indicates a statistically signiﬁcant difference between bri1/BRI1–mCit and the bri1/BRI125KR–mCit control (Mann–Whitney,
Po0.0001). (c) Western blot analyses on bri1/BRI1–mCitrine and bri1/BRI125KR–mCitrine plants using anti-GFP and anti-BES1 antibodies. The asterisk
indicates nonspeciﬁc signals used as loading control. (d) Quantiﬁcation of dephosphorylated BES1 (left) and BRI1 (right) protein levels in bri/BRI1–mCit and
bri1/BRI125KR–mCit. Experiments were carried out in triplicates. Error bars represent s.d. (n¼ 3). The asterisk indicates a statistically signiﬁcant difference in
dephosphorylated BES1 and BRI1 levels between bri1/BRI1–mCit and bri1/BRI125KR–mCit (Mann–Whitney, Po0.05). (e) Confocal microscopy analyses of
bri1/BRI1–mCitrine and bri1/BRI125KR–mCitrine roots. Scale bars¼ 7mm. (f) Quantiﬁcation of the ratio between plasma membrane and intracellular
ﬂuorescence signal intensities of BRI1–mCitrine and BRI125KR–mCitrine. Experiments were carried out in triplicates. Error bars represent s.d. (n¼ 15). The
asterisk indicates a statistically signiﬁcant difference between bri1/BRI1–mCit and the bri1/BRI125KR–mCit (Mann-Whitney, Po0.0005).
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lysines are required for receptor activation. BRI125KR–mCitrine-
expressing plants were severely compromised for BRI1
ubiquitination compared with BRI1–mCitrine (Supplementary
Fig. 5b,c). Interestingly, BRI125KR-expressing plants showed long
bending petioles and narrow leaf blades (Fig. 5a,b; Supplementary
Fig. 5d), reminiscent of what is observed in BRI1
overexpressors33. This correlates with increased accumulation of
dephosphorylated BES1, which positively regulates BR signalling1
(Fig. 5c,d). The BR hypersensitivity phenotype of BRI125KR is
observed for plants that express less BRI1 proteins than bri1/
BRI1–mCitrine plants (Fig. 5c,d), highlighting further the
negative role played by ubiquitination on BRI1 activity.
The BRI1 protein is found under normal conditions at the
plasma membrane, but also in endosomal compartments (TGN/
EE and MVB; Fig. 5e)13,14. In contrast, BRI125KR–mCitrine was
found mostly at the cell surface, with little intracellular
compartments observed (Fig. 5e,f). To unravel the mechanism
leading the different intracellular distribution of BRI125KR–
mCitrine, we compared the endocytic trafﬁcking of BRI1–
mCitrine and BRI125KR–mCitrine. BFA inhibits the trafﬁcking
of membrane proteins from TGN/EE to MVB and recycling to
the plasma membrane, but allows endocytosis. Both BRI1–
mCitrine and BRI125KR–mCitrine accumulated in BFA
compartments in absence of de novo protein synthesis
(Fig. 6a,b), although the size of BFA bodies appeared smaller
for BRI125KR–mCitrine (Fig. 6c). This suggests that BRI125KR–
mCitrine undergoes internalization from the plasma membrane,
but presumably to a lesser extent than its wild-type counterpart so
that less BRI1 protein is trapped in BFA bodies. To obtain more
resolution and quantitative data on the dynamics of BRI1 and
BRI125KR at the cell surface, we implemented TIRF. TIRF
generates high-contrast images and allows studying the
dynamic behaviour of proteins at the plasma membrane. We
were unable to perform reproducible TIRF imaging at the root tip
likely because of the ovoid shape of the root tip and the presence
of root hairs in root samples, preventing good contacting with the
coverslip, a prerequisite for TIRF imaging. Hypocotyls from
etiolated seedlings have ﬂat cells suited with TIRF imaging
and their elongation strongly depends on BR perception by BRI1
(ref. 1). BRI1–mCitrine localized to the plasma membrane in
etiolated hypocotyl cells, but the TGN/EE pool of BRI1 was
difﬁcult to observe because of the large central vacuole
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Figure 6 | Loss of BRI1 ubiquitination impairs its internalization and vacuolar targeting. (a) Sensitivity of bri1/BRI1–mCitrine and bri1/BRI125KR–mCitrine
plants to BFA. Plants were pretreated with 100mM CHX for 1 h and exposed to 100mM CHX and 50mM BFA for 1 h. Scale bars¼ 7 mm. (b) Quantiﬁcation of
BFA body number in bri1/BRI1–mCit and bri1/BRI125KR–mCit roots. Experiments were carried out in triplicates. Error bars represent s.d. (n¼ 15). No
statistical difference if observed between bri1/BRI1–mCit and bri1/BRI125KR–mCit (Mann–Whitney, P40.05). (c) Quantiﬁcation of BFA body size in bri1/
BRI1–mCit and bri1/BRI125KR–mCit roots. Experiments were carried out in triplicates. Error bars represent s.d. (n¼ 15). The asterisk indicates a statistically
signiﬁcant difference between the two genotypes (Mann–Whitney, Po0.0001). (d) Kymograph analysis from TIRF movies of bri1/BRI1–mCitrine and bri1/
BRI125KR–mCitrine. The timescale is shown. (e) Time of residency at the plasma membrane of bri1/BRI1–mCitrine and bri1/BRI125KR–mCitrine. The
distribution was obtained from kymograph-based track length analyses (n¼ 350). (f) Sensitivity of BRI1–mCitrine and BRI125KR–mCitrine to dark growth
conditions. Light-grown seedlings were kept in the dark for 2 h before confocal imaging. Scale bars¼ 7 mm. (g) Quantiﬁcation of the ratio between relative
plasma membrane and intracellular ﬂuorescence signal intensities of BRI1–mCitrine and BRI125KR–mCitrine. Experiments were carried out in triplicates. Error
bars represent s.d. (n¼ 15). The asterisk indicates a statistically signiﬁcant difference between BRI1–mCit and the BRI125KR–mCit (Mann–Whitney,
Po0.0001).
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(Supplementary Fig. 6a). BRI1 trafﬁcking was found to be
sensitive to BFA in etiolated hypocotyl cells, as highlighted by the
intracellular aggregation of BRI1–mCitrine upon BFA treatment.
Finally, artiﬁcially ubiquitinated BRI1 failed to accumulate in
hypocotyl cells. Altogether, this indicates that BRI1 trafﬁcking in
etiolated hypocotyl cells mirrors what has been described in roots.
BRI1–mCitrine-expressing plants were therefore imaged using
TIRF microscopy over time and showed small diffraction-limited
ﬂuorescent spots (Supplementary Movies 1,2). These spots were
immobile on the (x,y) axis but dynamically appeared and
disappeared from the focal plane, thus representing fusion and
ﬁssion events at the cell surface. A similar pattern was observed
for BRI125KR–mCitrine, although the density of spots at the cell
surface was higher (Supplementary Fig. 6b). To grasp the role of
ubiquitination in BRI1 internalization from the plasma
membrane, we further analysed the dynamic behaviour of wild-
type BRI1 and BRI125KR using kymograph analysis. Kymographs
monitor on a single image the intensity at a given (x,y) location
over time, and allow determination of surface time residence for
wild-type BRI1 and BRI125KR by measuring track length (Fig. 6d).
The time of residency of BRI1–mCitrine at the cell surface was
widely distributed (Fig. 6e), but over 60% of the spots resided less
than 10 s at the plasma membrane. The distribution observed for
BRI125KR was markedly different, with most spots persisting
longer at the plasma membrane. The surface residence time
median values for BRI1 and BRI125KR were 7.2 and 28.6 s,
respectively (Supplementary Fig. 6c). These observations clearly
argue for a direct role of BRI1 ubiquitination in internalization
from the plasma membrane.
We next monitored the role of ubiquitination in BRI1 vacuolar
targeting. BRI1–mCitrine and BRI125KR–mCitrine were transferred
to dark conditions, which impair vacuolar lytic activity and allow
visualization of the pH-resistant mCitrine ﬂuorescent fusion
proteins targeted to the vacuole50, and monitored by confocal
microscopy. Consistently, BRI1–mCitrine showed vacuolar
accumulation after 2 h of darkness (Fig. 6f,g). However,
BRI125KR–mCitrine exhibited no vacuolar targeting within the
same time frame. Consistently, the ubiquitination-defective
BRI125KR is more stable than wild-type BRI1 (Supplementary
Fig. 6d,e). The inability of BRI125KR to reach the vacuole combined
to the increased cell surface accumulation suggest that BRI125KR
undergoes enhanced recycling to the cell surface. Endocytosed
BRI1 protein was previously shown to recycle to the cell surface by
BFA washout experiments51, in which the recovery of BRI1 at the
plasma membrane is monitored after BFA removal in the absence
of protein synthesis. We conﬁrmed that BRI1 both recycles at the
plasma membrane and is also targeted to the vacuole after BFA
washout, and observed that BRI125KR recycles more to the cell
surface (Supplementary Fig. 6f,g). Altogether, our results unravel
the dual role of BRI1 ubiquitination in BRI1 receptor
internalization from the plasma membrane and also in its
endosomal sorting and vacuolar targeting.
Discussion
The BR receptor BRI1 is the best-studied plant receptor and
serves as the archetypical receptor to study the activation/
deactivation mechanisms involved in receptor-mediated signal-
ling. Previous studies have shed light on the ligand-dependent
oligomerization and phosphorylation of the BRI1/BAK1 receptor
complex and have identiﬁed components of the BR signalling
pathway controlling BR genomic responses52. However, not
much is known about the mechanisms driving the trafﬁcking of
BRI1 and its turnover in relationship with signalling. In this
report, we show that BRI1 dynamics in the cell is controlled by
ubiquitination and unravel its role for BR-mediated plant growth.
Ubiquitination of proteins has been associated with many
different cellular outputs in yeast and mammals, depending on
the type of ubiquitination41. In the case of membrane proteins,
ubiquitination triggers endocytosis and vacuolar/lysosomal
degradation18. In plants, only a handful of integral membrane
proteins have been shown to undergo Ub-mediated endocytosis.
These examples are so far exclusively restricted to multispan
transporters involved in iron, boron or phosphate nutrition or in
auxin transport22–25. Both monoubiquitination and K63
polyubiquitination have been implicated in these examples,
consistent with their described roles in yeast and mammals.
Ubiquitination of plant receptors is still poorly documented,
although several E3-Ub ligases interacting with receptors have
been identiﬁed27–30. Only the Flagellin receptor FLS2 involved in
plant immune responses has been shown to be ubiquitinated31.
However, FLS2 carries K48 polyubiquitin chains and has been
suggested to be degraded by the proteasome.
In this study, we ﬁrst demonstrated using a gain-of-function
approach that the artiﬁcial ubiquitination of BRI1 is sufﬁcient for
destabilizing the corresponding protein. Artiﬁcial monoubiquiti-
nation of BRI1 appeared sufﬁcient to prevent accumulation of
BRI1. Destabilization of the BRI1–mCitrine–Ub protein involves
trafﬁcking through the TGN/EE and degradation in the vacuole,
based on the strong accumulation of BRI1–mCitrine–Ub
following treatments with BFA and ConA. Inhibition of
clathrin-mediated endocytosis, the major BRI1 endocytic
route15,16, with TyrA23 failed to stabilize BRI1–mCitrine–Ub at
the cell surface, suggesting that the artiﬁcially ubiquitinated BRI1
variant never reaches the plasma membrane. Formally, artiﬁcially
ubiquitinated BRI1 could be rapidly endocytosed from the plasma
membrane using a clathrin-independent TyrA23-insensitive
pathway. However, we favour the hypothesis that BRI1–
mCitrine–Ub is recognized at the TGN/EE and diverted away
from the secretory pathway before it reaches the cell surface,
being directly routed to the vacuole for degradation. In yeast and
mammals, GGA proteins at the TGN work to divert ubiquitinated
cargos from the secretory pathway towards endosomes,
preventing them from reaching the cell surface53. Late
endocytic sorting of ubiquitinated cargos in intraluminal
vesicles of MVB and vacuolar/lysosomal targeting require the
late endosome-located ESCRT complex18. In plants, the TOL
GGA-related proteins and several subunits of the ESCRT
complex have been recently detected in TGN/EE54,55, indicating
that the sorting of artiﬁcially ubiquitinated BRI1 indeed occurs at
the TGN/EE.
We demonstrated that BRI1 is K63 polyubiquitinated in vivo,
and does not carry K48 polyubiquitin chains. The combination of
ubiquitination site identiﬁcation by mass spectrometry and
model-based prediction allowed us to generate a functional
ubiquitination-defective BRI125KR mutant form. In contrast to
wild-type BRI1 that shows signiﬁcant endosomal localization13,
BRI125KR was mostly found at the cell surface. To decipher
whether the increased plasma membrane localization resulted
from internalization defects and/or intracellular sorting defects,
we implemented TIRF microscopy to speciﬁcally monitor BRI1
dynamics at the cell surface. Such analysis ﬁrst highlighted the
highly dynamic behaviour of wild-type BRI1, with extremely
rapid fusion and ﬁssion events within the seconds range.
Interestingly, BRI125KR shows much slower fusion/ﬁssion events
at the plasma membrane, within the tens of second range,
indicating that ubiquitination of BRI1 triggers its internalization
from the cell surface. Detailed analysis of BRI125KR trafﬁcking
also highlighted the crucial role of ubiquitination in BRI1
intracellular sorting and vacuolar targeting. Overall,
ubiquitination of BRI1 therefore appears as one several
redundant mechanisms driving BRI1 internalizing from the
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plasma membrane, whereas it is absolutely essential for BRI1
endosomal sorting (Fig. 7). The combination of both slower
internalization and forced recycling caused by vacuolar targeting
defects are therefore the basis of increased BRI125KR at the cell
surface and increased spot density. This scenario is reminiscent of
what is currently debated for the epidermal growth factor
receptor (EGFR) in animals. Mutation of 15 ubiquitin
conjugation sites found in the EGFR kinase domain or the Cbl
E3 ligase-binding site does not affect EGFR internalization,
although preventing lysosomal degradation56. EGFR
internalization from the cell surface is impaired only when 21
lysine residues in the kinase domain and C-terminal domain are
mutated, although the three distal lysines in the C-terminal
domain appeared to be acetylated in vivo21. EGFR internalization
is dependent on many redundant lysine residues and involves
several redundant and cooperative mechanisms21. Altogether,
although artiﬁcial monoubiquitination of several cargos is
sufﬁcient for endocytosis, the presence of K63 polyubiquitin
chains appears either critical for intracellular sorting or likely
accelerates this process by increasing the avidity for Ub-binding
proteins20,57–61. Similar observations likely applies to BRI1 Ub-
mediated endocytosis.
Modiﬁcation of BRI1 with Ub negatively regulates BRI1
function and BR signalling, as attested by the BR-hypersensitive
phenotypes displayed by transgenic plants impaired in BRI1
ubiquitination. BRI1 ubiquitination is however largely independent
of ligand binding, with only a transient increase in ubiquitination
observed after a short-term BL treatment. This is consistent with
previous observations showing that BRI1 turnover is only mildly
modulated by the presence or absence of BRs13. BRI1
ubiquitination however required BRI1 kinase activity and the
presence of its co-receptor BAK1, both mechanisms being
dependent on BRs. One explanation is that in the absence of
steroids, BRI1 kinase shows basal kinase activity sufﬁcient for
triggering phosphorylation of important residues for
ubiquitination in BRI1 but not involved in signalling. The
requirement for BAK1 is puzzling considering the BR
dependency of BRI1/BAK1 interaction. However, recent evidence
based on FRET-FLIM analyses indicates that signiﬁcant proportion
of BRI1 and BAK1 interact at the cell surface even in the absence of
ligand62. These different observations clarify how BRI1
ubiquitination may rely on hallmarks of BR receptor complex
activation, although independently of ligand perception. The
ability of BRI1 to signal from endosomes has been highly
debated recently13. The increased plasma membrane localization
of BRI125KR, associated with enhanced BR signalling, conﬁrms
recent evidence pointing to the initiation of BR signalling at the cell
surface15,16. BRI1 ubiquitination appears as a mechanism
controlling the dynamics of BRI1 in the cell and thus has an
impact on BR signalling, although in a BR-independent manner.
Whether endogenous/exogenous cues may have an impact on
BRI1 ubiquitination and thus affect BR-dependent growth will
have to be investigated in the future.
Methods
Plant material and constructs. Wild-type (Col0), bak1-3 (ref. 63), bri1 T-DNA
knockout32 and the various transgenic plants generated in this study were grown at
21 C with 16 h light/8 h dark cycles. The transgenic lines BRI1::BRI1-mCitrine,
bri1/BRI1::BRI1-mCitrine, bak1-3/BRI1::BRI1-mCitrine and kinase-dead
BRI1::BRI1K911R-mCitrine express BRI1 under the control of its own promoter and
were previously characterized32,33.
mCitrine–Ub and mCitrine–Ub7KR fusions were cloned into pDONR-P2RP3
(Invitrogen). BRI1K866R and BRI125KR were cloned in pDONR221 (Invitrogen).
Final destination vectors were obtained by using three-fragment recombination
system using the pB7m34GW destination vectors64, and the entry vectors pDONR-
P4P1r-BRI1prom32, pDONR221-BRI1 or mutated BRI1 versions, and pDONR-
P2rP3-mCitrine32, mCitrine–Ub or mCitrine–Ub7KR. The resulting constructs
expressing BRI1 variants under the control of its own promoter were transformed
into heterozygous bri1 null mutant or wild-type plants. For all constructs, more
than 50 independent T1 lines were isolated and between three to six representative
mono-insertion lines were selected in T2. Independent lines homozygous for the
transgene when transformed in wild-type background, or for both bri1 mutation
and the transgene when transformed in bri1 mutants, were selected in T3. Confocal
microscopy, phenotypic analysis and protein extraction were performed on
representative mono-insertional homozygous T3 lines (Supplementary Table 1).
Chemical treatments. Inhibitors (Sigma-Aldrich) were used at the following
concentrations: 2 mM ConcA (2mM DMSO stock), 50 mM BFA (20mM DMSO
stock), 33mM TyrA23 (50mM DMSO stock) and 100 mM cycloheximide (CHX;
100mM EtOH stock). BL (Chemiclones, 1mM stock in DMSO) and BRZ (Che-
miclones, 10mM stock in DMSO) were used at concentrations indicated in the
ﬁgure legends.
Hypocotyl and petiole length assays. Hypocotyl and petiole lengths from 15
seedlings were measured with ImageJ 1.48d on days 4 and 28, respectively. All
dose–response hypocotyl elongation assays and petiole length experiments were
performed in triplicates. For hypocotyl assays, imbibed seeds were stratiﬁed at 4 C
for 4 days and care was taken that seed germination occurs simultaneously between
the different genotypes.
Gene expression analyses. Total RNA was extracted from whole plants using the
RNeasy RNA extraction kit (Qiagen). SuperScript reverse transcriptase (Life
Technologies) was used to synthesize cDNA from RNA. Semi-quantitative PCR
using the gene-speciﬁc primers are listed in Supplementary Table 2.
Immunoprecipitation and western blot analysis. Protein extraction and
immunoprecipitation experiments were conducted using 12-day-old seedlings. For
western blot analyses, total proteins were extracted from B100mg of starting
material. For protein detection, the following antibodies were used: Monoclonal
anti-GFP horseradish peroxidase-coupled (Miltenyi Biotech 130-091-833, 1/5,000),
anti-ubiquitin P4D1 (Millipore 05-944, 1/2,500), anti K48 polyubiquitin Apu2
(Millipore 05-1,307, 1/2,000) and anti-K63 polyubiquitin Apu3 (Millipore 05-
1,308, 1/2,000)34, anti-BRI1 (ref. 65) (1/2000) and anti-BES1 (ref. 12) 1/5000). BRI1
protein stability was determined by blocking de novo BRI1 protein synthesis with
PM
EE/TGN
MVB
Vacuole
?
Figure 7 | Model for the role of ubiquitination in BRI1 endocytosis.
Ubiquitination of BRI1 acts at the cell surface, redundantly with other
mechanisms, to mediate BRI1 internalization. Internalized BRI1 may be
deubiquitinated and recycled to the plasma membrane, or sorted into late
endosomal compartments for vacuolar delivery. Ubiquitination of BRI1 is
essential for proper sorting and targeting to the vacuole.
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100mM CHX. Quantiﬁcation of western blot was performed using the
Densitometry plugin from Image J. Immunoprecipitation experiments were
performed using 1 g of seedlings. Tissues were ground in liquid nitrogen and
resuspended in 2ml of ice-cold sucrose buffer (20mM Tris, pH 8; 0.33M Sucrose;
1mM EDTA, pH 8; protease inhibitor). Samples were then centrifuged for 10min
at 5,000 g at 4 C. Total proteins contained in the supernatant were centrifuged at
4 C for 45min at 20,000 g to pellet microsomes. The pellet was resuspended in
1ml of immunoprecipitation buffer (50mM Tris pH 8, 150mM NaCl, 1% Triton
X-100) using a 2-ml potter-Elvehjem homogenizer and was left on a rotating wheel
for 30min at 4 C. Non-resuspended material was then pelleted for 10min at
20,000 g and 4 C. The supernatant contained the fraction enriched in
microsomal-associated proteins. Immunoprecipitations were carried out on 1mg
of microsomal proteins using the mMACS GFP isolation kit (Miltenyi Biotec). For
quantiﬁcation of BRI1-ubiquitinated pools, the ratio of normalized
immunoprecipitation signal intensity obtained with anti-GFP and anti-Ub
antibodies was determined using Image J. Immunoprecipitation and western blot
analyses were performed in triplicates. Representative blots are shown in ﬁgures,
and full scan blots in Supplementary Fig. 7.
Mass spectrometry. Immunopuriﬁed proteins were reduced with dithiothreitol,
alkylated with iodoacetamide and digested with trypsin overnight. Salts and
reagents were removed by reversed phase (C-18) cartridge clean-up. The salt-free
peptides were dissolved in 0.1% formic acid and subjected to ESI-MS/MS analysis
on a Thermo LTQ-Orbitrap XL instrument. A capillary column (inner diameter
75mm, packing length 10 cm of C-18 silica) with integrated spray tip was used with
a 300 nlmin 1 0.1% formic acid/acetonitrile gradient. Peptide precursor masses
were determined with high accuracy by Fourier transform MS in the Orbitrap
followed by data-dependent MS/MS of the top ﬁve precursor ions in each
chromatographic time window. Data were analysed using the Mascot algorithm
(Matrix Science, London, UK on a local Mascot server (version 2.1.0) and searched
against the latest Swiss Protein database allowing a variable isopeptide (Gly–Gly)
modiﬁcation on lysine residues.
Confocal microscopy. Plant samples were mounted in water and viewed on Leica
TCS SP2 confocal laser scanning microscopes. Images were taken at the root tip from
7-day-old plants grown in the light, or in the upper part of 4-day-old etiolated
hypocotyls. For imaging mCitrine fusion proteins, the 514-nm laser line was used.
Laser intensity settings were kept constant in individual sets of experiments to allow
for a comparison of expression and localization of reporter proteins. Quantiﬁcation
of total ﬂuorescence intensity in roots, at the plasma membrane, in intracellular
compartments, in BFA bodies or in the vacuole was performed using Image J.
TIRF microscopy and analysis of images. Arabidopsis plantlets were grown in
MS medium for 4 days in the dark to obtain etiolated hypocotyls. Hypocotyls were
imaged by TIRF on a Nikon Eclipse Ti microscope equipped with a Nikon APO
TIRF  100/1.49 oil immersion objective. The excitation wavelength used was
491 nm provided by a 100-mW diode laser Toptica AOTF and emission light was
collected with an emission ﬁlter Chroma ET 525/50. Time lapses were acquired
during 2min at 200-ms intervals and images were captured with a Photometrics
Evolve Delta Camera using the Metamorph Software version 7.7.9.0 (Molecular
Devices, LLC) and the laser power at 40%.
The videos of three independent experiments were then analysed using the
ImageJ 1.48d software. To better visualize the videos, the Difference of Gaussian
ﬁlter and the kymographs were obtained on the treated images using the
MultiKymographs plugin (http://www.embl.de/eamnet/html/
body_kymograph.html) of ImageJ. The time of residence was determined by the
duration of tracks (n¼ 350). To measure the density of BRI1 and BRI125KR at the
plasma membrane, videos were treated with the Difference of Gaussian ﬁlter and
the density of protein was quantiﬁed by the Find Maxima function within a region
of same area using ROI manager. Each area measured was 40 41 pixels (0.160 mm
per pixel) in size.
Statistical analyses. Statistical analyses were performed with the software
GraphPad Prism. Physiological plant parameters (hypocotyl and petiole length),
western blot and immunoprecipitation quantiﬁcation used the non-parametric
Mann–Whitney test (two genotypes/conditions) or the non-parametric
Kruskal–Wallis (three genotypes/conditions and more) test followed by a Dunn’s
or Dunnet’s post hoc test for multiple comparisons (Po0.05).
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